Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

<h4>Background</h4>The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants.<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M Garland, Paulo Naud, Johanna Palmroth, Maria Rowena Del Rosario-Raymundo, Cosette M Wheeler, Jorge Salmerón, Song-Nan Chow, Dan Apter, Julio C Teixeira, S Rachel Skinner, James Hedrick, Anne Szarewski, Barbara Romanowski, Fred Y Aoki, Tino F Schwarz, Willy A J Poppe, F Xavier Bosch, Newton S de Carvalho, Maria Julieta Germar, Klaus Peters, Jorma Paavonen, Marie-Cecile Bozonnat, Dominique Descamps, Frank Struyf, Gary O Dubin, Dominique Rosillon, Laurence Baril, HPV PATRICIA Study Group
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f961d1ec4e5d4146871f6301cdfc1d02
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f961d1ec4e5d4146871f6301cdfc1d02
record_format dspace
spelling oai:doaj.org-article:f961d1ec4e5d4146871f6301cdfc1d022021-11-18T08:45:37ZNatural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.1932-620310.1371/journal.pone.0079260https://doaj.org/article/f961d1ec4e5d4146871f6301cdfc1d022013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260180/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants.<h4>Methods and findings</h4>Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 type-specific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3+ associated with the same HPV type as a 6MPI; CIN1+/CIN2+/CIN3+ associated with an infection of any duration; and clearance of infection. The analyses included 4825 women with 16,785 infections (3363 women with 6902 6MPIs). Risk of developing a CIN1+/CIN2+/CIN3+ associated with same HPV type as a 6MPI varied with HPV type and was significantly higher for oncogenic versus non-oncogenic types. Hazard ratios for development of CIN2+ were 10.44 (95% CI: 6.96-15.65), 9.65 (5.97-15.60), 5.68 (3.50-9.21), 5.38 (2.87-10.06) and 3.87 (2.38-6.30) for HPV-16, HPV-33, HPV-31, HPV-45 and HPV-18, respectively. HPV-16 or HPV-33 6MPIs had ~25-fold higher risk for progression to CIN3+. Previous or concomitant HPV infection or CIN1+ associated with a different HPV type increased risk. Of the different oncogenic HPV types, HPV-16 and HPV-31 infections were least likely to clear.<h4>Conclusions</h4>Cervical infections with oncogenic HPV types increased the risk of CIN2+ and CIN3+. Previous or concomitant infection or CIN1+ also increased the risk. HPV-16 and HPV-33 have by far the highest risk of progression to CIN3+, and HPV-16 and HPV-31 have the lowest chance of clearance.Unnop JaisamrarnXavier CastellsaguéSuzanne M GarlandPaulo NaudJohanna PalmrothMaria Rowena Del Rosario-RaymundoCosette M WheelerJorge SalmerónSong-Nan ChowDan ApterJulio C TeixeiraS Rachel SkinnerJames HedrickAnne SzarewskiBarbara RomanowskiFred Y AokiTino F SchwarzWilly A J PoppeF Xavier BoschNewton S de CarvalhoMaria Julieta GermarKlaus PetersJorma PaavonenMarie-Cecile BozonnatDominique DescampsFrank StruyfGary O DubinDominique RosillonLaurence BarilHPV PATRICIA Study GroupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79260 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Unnop Jaisamrarn
Xavier Castellsagué
Suzanne M Garland
Paulo Naud
Johanna Palmroth
Maria Rowena Del Rosario-Raymundo
Cosette M Wheeler
Jorge Salmerón
Song-Nan Chow
Dan Apter
Julio C Teixeira
S Rachel Skinner
James Hedrick
Anne Szarewski
Barbara Romanowski
Fred Y Aoki
Tino F Schwarz
Willy A J Poppe
F Xavier Bosch
Newton S de Carvalho
Maria Julieta Germar
Klaus Peters
Jorma Paavonen
Marie-Cecile Bozonnat
Dominique Descamps
Frank Struyf
Gary O Dubin
Dominique Rosillon
Laurence Baril
HPV PATRICIA Study Group
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
description <h4>Background</h4>The control arm of PATRICIA (PApilloma TRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants.<h4>Methods and findings</h4>Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 type-specific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3+ associated with the same HPV type as a 6MPI; CIN1+/CIN2+/CIN3+ associated with an infection of any duration; and clearance of infection. The analyses included 4825 women with 16,785 infections (3363 women with 6902 6MPIs). Risk of developing a CIN1+/CIN2+/CIN3+ associated with same HPV type as a 6MPI varied with HPV type and was significantly higher for oncogenic versus non-oncogenic types. Hazard ratios for development of CIN2+ were 10.44 (95% CI: 6.96-15.65), 9.65 (5.97-15.60), 5.68 (3.50-9.21), 5.38 (2.87-10.06) and 3.87 (2.38-6.30) for HPV-16, HPV-33, HPV-31, HPV-45 and HPV-18, respectively. HPV-16 or HPV-33 6MPIs had ~25-fold higher risk for progression to CIN3+. Previous or concomitant HPV infection or CIN1+ associated with a different HPV type increased risk. Of the different oncogenic HPV types, HPV-16 and HPV-31 infections were least likely to clear.<h4>Conclusions</h4>Cervical infections with oncogenic HPV types increased the risk of CIN2+ and CIN3+. Previous or concomitant infection or CIN1+ also increased the risk. HPV-16 and HPV-33 have by far the highest risk of progression to CIN3+, and HPV-16 and HPV-31 have the lowest chance of clearance.
format article
author Unnop Jaisamrarn
Xavier Castellsagué
Suzanne M Garland
Paulo Naud
Johanna Palmroth
Maria Rowena Del Rosario-Raymundo
Cosette M Wheeler
Jorge Salmerón
Song-Nan Chow
Dan Apter
Julio C Teixeira
S Rachel Skinner
James Hedrick
Anne Szarewski
Barbara Romanowski
Fred Y Aoki
Tino F Schwarz
Willy A J Poppe
F Xavier Bosch
Newton S de Carvalho
Maria Julieta Germar
Klaus Peters
Jorma Paavonen
Marie-Cecile Bozonnat
Dominique Descamps
Frank Struyf
Gary O Dubin
Dominique Rosillon
Laurence Baril
HPV PATRICIA Study Group
author_facet Unnop Jaisamrarn
Xavier Castellsagué
Suzanne M Garland
Paulo Naud
Johanna Palmroth
Maria Rowena Del Rosario-Raymundo
Cosette M Wheeler
Jorge Salmerón
Song-Nan Chow
Dan Apter
Julio C Teixeira
S Rachel Skinner
James Hedrick
Anne Szarewski
Barbara Romanowski
Fred Y Aoki
Tino F Schwarz
Willy A J Poppe
F Xavier Bosch
Newton S de Carvalho
Maria Julieta Germar
Klaus Peters
Jorma Paavonen
Marie-Cecile Bozonnat
Dominique Descamps
Frank Struyf
Gary O Dubin
Dominique Rosillon
Laurence Baril
HPV PATRICIA Study Group
author_sort Unnop Jaisamrarn
title Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
title_short Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
title_full Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
title_fullStr Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
title_full_unstemmed Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
title_sort natural history of progression of hpv infection to cervical lesion or clearance: analysis of the control arm of the large, randomised patricia study.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f961d1ec4e5d4146871f6301cdfc1d02
work_keys_str_mv AT unnopjaisamrarn naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT xaviercastellsague naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT suzannemgarland naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT paulonaud naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT johannapalmroth naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT mariarowenadelrosarioraymundo naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT cosettemwheeler naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT jorgesalmeron naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT songnanchow naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT danapter naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT juliocteixeira naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT srachelskinner naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT jameshedrick naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT anneszarewski naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT barbararomanowski naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT fredyaoki naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT tinofschwarz naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT willyajpoppe naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT fxavierbosch naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT newtonsdecarvalho naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT mariajulietagermar naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT klauspeters naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT jormapaavonen naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT mariececilebozonnat naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT dominiquedescamps naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT frankstruyf naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT garyodubin naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT dominiquerosillon naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT laurencebaril naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
AT hpvpatriciastudygroup naturalhistoryofprogressionofhpvinfectiontocervicallesionorclearanceanalysisofthecontrolarmofthelargerandomisedpatriciastudy
_version_ 1718421361065459712